The 2020 ACC/AHA executive summary provides updated evidence-based recommendations for the diagnosis, surgical and catheter interventions, and medical management of valvular heart disease.
The 2020 ACC/AHA guideline provides updated, evidence-based recommendations for the diagnosis and management of valvular heart disease.
AIM This executive summary of the valvular heart disease guideline provides recommendations for clinicians to diagnose and manage valvular heart disease as well as supporting documentation to encourage their use. METHODS A comprehensive literature search was conducted from January 1, 2010, to March 1, 2020, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, Cochrane, Agency for Healthcare Research and Quality Reports, and other selected database relevant to this guideline. STRUCTURE Many recommendations from the earlier valvular heart disease guidelines have been updated with new evidence and provides newer options for diagnosis and treatment of valvular heart disease. This summary includes only the recommendations from the full guideline which focus on diagnostic work-up, the timing and choice of surgical and catheter interventions, and recommendations for medical therapy. The reader is referred to the full guideline for graphical flow charts, text, and tables with additional details about the rationale for and implementation of each recommendation, and the evidence tables detailing the data considered in developing these guidelines.
“Current research and new technology continue to transform the treatment of heart valve disease, as updated lifestyle and medication guidance evolve, and less invasive procedures have replaced traditional surgery for many patients.”
Otto et al. (2020) conducted a review in Valvular heart disease. Guideline recommendations was evaluated. The 2020 ACC/AHA executive summary provides updated evidence-based recommendations for the diagnosis, surgical and catheter interventions, and medical management of valvular heart disease.